SE0101386D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0101386D0
SE0101386D0 SE0101386A SE0101386A SE0101386D0 SE 0101386 D0 SE0101386 D0 SE 0101386D0 SE 0101386 A SE0101386 A SE 0101386A SE 0101386 A SE0101386 A SE 0101386A SE 0101386 D0 SE0101386 D0 SE 0101386D0
Authority
SE
Sweden
Prior art keywords
new compounds
compounds
analogs
preparing
pharmaceutical compositions
Prior art date
Application number
SE0101386A
Other languages
English (en)
Inventor
Krister Bamberg
Lanna Li
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0101386A priority Critical patent/SE0101386D0/sv
Publication of SE0101386D0 publication Critical patent/SE0101386D0/sv
Priority to PCT/SE2002/000770 priority patent/WO2002085844A1/en
Priority to JP2002583372A priority patent/JP4209684B2/ja
Priority to US10/475,054 priority patent/US7169810B2/en
Priority to EP02724851A priority patent/EP1383739A1/en
Priority to US11/612,706 priority patent/US20070149614A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
SE0101386A 2001-04-20 2001-04-20 New compounds SE0101386D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0101386A SE0101386D0 (sv) 2001-04-20 2001-04-20 New compounds
PCT/SE2002/000770 WO2002085844A1 (en) 2001-04-20 2002-04-18 New compounds
JP2002583372A JP4209684B2 (ja) 2001-04-20 2002-04-18 新しい化合物
US10/475,054 US7169810B2 (en) 2001-04-20 2002-04-18 Guanidine and amidine acid derivatives and analogs and methods of using the same
EP02724851A EP1383739A1 (en) 2001-04-20 2002-04-18 New compounds
US11/612,706 US20070149614A1 (en) 2001-04-20 2006-12-19 Guanidine and amidine acid derivatives and analogs and methods of using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101386A SE0101386D0 (sv) 2001-04-20 2001-04-20 New compounds

Publications (1)

Publication Number Publication Date
SE0101386D0 true SE0101386D0 (sv) 2001-04-20

Family

ID=20283821

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101386A SE0101386D0 (sv) 2001-04-20 2001-04-20 New compounds

Country Status (5)

Country Link
US (2) US7169810B2 (sv)
EP (1) EP1383739A1 (sv)
JP (1) JP4209684B2 (sv)
SE (1) SE0101386D0 (sv)
WO (1) WO2002085844A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
SE0101386D0 (sv) * 2001-04-20 2001-04-20 Astrazeneca Ab New compounds
WO2005040127A1 (en) * 2003-10-27 2005-05-06 Lg Life Sciences Ltd. Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same
JP2021014405A (ja) * 2017-10-16 2021-02-12 味の素株式会社 甘味受容体アンタゴニスト

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60311C2 (uk) 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
AU747503B2 (en) 1999-02-03 2002-05-16 Merck & Co., Inc. Benzazepine derivatives as alpha-V integrin receptor antagonists
WO2000048603A1 (en) 1999-02-17 2000-08-24 Merck & Co., Inc. DIBENZO-AZEPINE DERIVATIVES AS αV INTEGRIN RECEPTOR ANTAGONISTS
SE9904421D0 (sv) 1999-12-03 1999-12-03 Astra Ab New compounds
SE0101386D0 (sv) * 2001-04-20 2001-04-20 Astrazeneca Ab New compounds

Also Published As

Publication number Publication date
WO2002085844A1 (en) 2002-10-31
JP2004527546A (ja) 2004-09-09
EP1383739A1 (en) 2004-01-28
US20070149614A1 (en) 2007-06-28
JP4209684B2 (ja) 2009-01-14
US20040138300A1 (en) 2004-07-15
US7169810B2 (en) 2007-01-30

Similar Documents

Publication Publication Date Title
SE9801992D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative I
SE0001899D0 (sv) New compounds
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
TW200503674A (en) Therapeutic agents
MY135920A (en) New phenalkyloxy-phenyl derivatives
BR0207726A (pt) Sais farmacêuticos
SE9904421D0 (sv) New compounds
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
BR0108678A (pt) Novos compostos
NO20031273L (no) Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
TW200626527A (en) Novel hexafluoroisopropanol derivatives
BR0314898A (pt) Compostos, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica
NO20042158L (no) Substituert 4-fenyl-tetrahydroisokinoliner, fremgangsmate for fremstilling derav, anvendelse derav som medikamenter, i tillegg til medikamenter inneholdende samme
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
UA83832C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
SE0101978D0 (sv) New compounds
ATE284878T1 (de) Pharmazeutische verbindungen mit serotonin rezeptor aktivität
SE0101386D0 (sv) New compounds
SE0300457D0 (sv) Novel compounds
NO20053876D0 (no) Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav
EE05490B1 (et) Parendatud toimega tsklilise depsipeptiidi kristallivorm
ATE395936T1 (de) Dichloracetat in kombination mit kardioprotektiven oder hämodynamischen medikamenten
TW200503999A (en) Therapeutic agents
ECSP034713A (es) Sales de adicion de acido malico de terbinafina
BR9916858A (pt) ((aminoiminometil)amino)alcanocarboxamidas e asaplicações das mesmas em terapia